Topical nasal decongestant sprays — oxymetazoline, xylometazoline, ephedrine — are some of the most effective ways to unblock a nose quickly. They are also one of the commonest causes of a problem called rhinitis medicamentosa, where the nose becomes dependent on the spray and feels worse than ever when it is not used.
UK community pharmacies see this pattern frequently. The counter advice is short, consistent, and supported by NICE CKS: the maximum useful course of a topical decongestant is around seven days, and anyone who has been using one for longer usually needs a structured taper rather than a cold turkey stop.
What actually happens inside the nose
Decongestant sprays work by constricting the blood vessels in the nasal mucosa, which reduces swelling and re-opens the airway. With repeated use — typically beyond 5 to 10 days — the receptors down-regulate. When the spray is stopped, the vessels rebound and dilate more than they did before. The nose feels more blocked. Another spray fixes it. The cycle repeats.
This is rhinitis medicamentosa. It is a physiological adaptation, not a true allergy. NHS patient information on decongestants is explicit that topical sprays should not be used for more than a week.
Who presents at the pharmacy
A typical pharmacy consultation will involve someone who started a spray for a cold or after a flight and has kept using it for weeks or months. They will often describe a progressively shorter duration of relief per dose, and a nose that is significantly worse at night or first thing in the morning.
The pharmacist's job is to recognise this, reassure the patient that it is reversible, and set up a taper.
The UK pharmacy taper
There is no single national protocol, but the common UK approach — reflected in both NICE CKS on common cold and community practice — is a stepped approach:
- Switch one nostril. Stop the spray in one nostril while continuing in the other. The treated nostril eventually clears; the untreated one demonstrates that normal breathing is possible.
- Switch to saline. Use a saline nasal spray (plain sodium chloride, preservative-free where possible) several times a day. This rehydrates the mucosa and helps clear debris.
- Start an intranasal corticosteroid. Fluticasone, beclometasone and mometasone nasal sprays are available over the counter or on GP prescription. They take up to two weeks to reach full effect. Started during the taper, they cover the rebound period.
- Add a non-sedating oral antihistamine if allergy is also playing a role. Loratadine, cetirizine or fexofenadine are first-choice options in NICE CKS on allergic rhinitis.
A realistic taper runs two to four weeks. Patients should be warned the first three to five days will feel uncomfortable.
The medicines involved
| Class | Examples | OTC status | Role |
|---|---|---|---|
| Topical alpha-agonist | Xylometazoline, oxymetazoline, ephedrine | Pharmacy (P) | Short-term decongestion only — limit 7 days |
| Saline | Sterimar, own-label sodium chloride | General sales list | Safe long-term; supports taper |
| Intranasal corticosteroid | Fluticasone, beclometasone, mometasone | P (age-limited) / POM for higher strength | Long-term treatment of underlying rhinitis |
| Oral antihistamine | Loratadine, cetirizine, fexofenadine | GSL / P depending on product | Allergic component |
Phenylephrine and pseudoephedrine are systemic oral decongestants rather than topical sprays. They work differently and do not cause the same local rebound pattern, although they have their own cautions (hypertension, cardiac disease) that a pharmacist will check.
When the pharmacy refers
NICE CKS prompts referral to the GP when:
- Rhinitis persists despite appropriate OTC management for at least two weeks
- There is unilateral blockage, bleeding or crusting (which can indicate structural or malignant disease)
- There are features of sinusitis needing review under the Pharmacy First sinusitis pathway or GP
- The patient is pregnant, breastfeeding, or under 16 and an intranasal corticosteroid is being considered
How pharmacies fit the wider care pathway
Community pharmacies are the first line of defence against over-use of decongestant sprays in the UK, and the Pharmacy First scheme in England already covers sinusitis, which is a common reason people reach for the spray in the first place. The PharmSee pharmacy finder helps locate a nearby community pharmacy that can book a Pharmacy First appointment; for anyone curious about the workforce behind this, the PharmSee jobs data shows how the community sector is currently hiring.
Caveats and sources
Advice here summarises current UK NHS and NICE guidance as of April 2026. Individual clinical circumstances vary; nothing in this article replaces a pharmacist or GP consultation. Intranasal steroid products vary in age licensing and available strength — always check the specific pack.
Sources: NICE CKS on common cold; NICE CKS on allergic rhinitis; NHS patient information on decongestants; BNF treatment summary on nasal congestion.